FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, specifically to peptide inhibitors of thrombin, and can be used in medicine for prevention or treatment of a disease associated with thrombosis, as well as for detecting the accumulation of thrombin in a subject.
EFFECT: invention provides production of peptides that are able to bind to thrombin with a high level of specificity and inhibit its activity.
19 cl, 28 dwg, 7 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING CONDITIONS ASSOCIATED WITH MASP-2-DEPENDENT COMPLEMENT ACTIVATION | 2014 |
|
RU2718850C2 |
| METHODS OF TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION | 2012 |
|
RU2743409C2 |
| ANTIBODIES TO FACTOR XI AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2739946C2 |
| CHIMERIC HUMAN MESOTHELIOGEN ANTIGEN RECEPTORS AND USE THEREOF | 2014 |
|
RU2714902C2 |
| AIMED AT UPARAP ANTIBODY-DRUG CONJUGATES | 2017 |
|
RU2740311C2 |
| PEPTIDE FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2788083C2 |
| DNA ANTIBODY CONSTRUCTIONS FOR USE AGAINST LYME DISEASE | 2017 |
|
RU2813829C2 |
| ANTI-αvβ8 ANTIBODIES AND COMPOSITIONS AND THEIR USE | 2019 |
|
RU2812478C2 |
| ANTI-C5 ANTIBODIES AND THEIR USE | 2018 |
|
RU2774716C2 |
| IMMUNOGLOBULIN WITH ONE VARIABLE DOMAIN AGAINST RSV F-PROTEIN | 2016 |
|
RU2730671C2 |
